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brain as one of the most affected organs refl ecting severe 
and long-term cognitive and motor defi cits ( 5, 6 ). Yet, no 
effective therapies are available, except for hypothermia 
in term neonates suffering from moderate encephalopa-
thy ( 7 ). There is, however, evidence that molecular mech-
anisms of organ preconditioning result in tissue tolerance 
to a following more severe insult that would otherwise be 
lethal ( 8 ). Previously, we have shown in a rat model that fetal 
asphyxia, induced at embryonic day 17 (E17) by clamping 
the uterine vasculature for 30 min , induces brain tolerance 
to a stronger PA insult ( 9, 10 ). Moreover, less apoptotic cell 
death was seen in brains of Fetal asphyctic preconditioned 
animals compared with nonpreconditioned animals sub-
jected to PA ( 10 ). Hence, the identifi cation of the signal-
ing pathways and effectors involved in brain tolerance is of 
primary importance for the development of new neuro-
protective therapies. 
 Important mechanisms may involve changes in ceramide 
levels which have been reported in various models of hy-
poxia/ischemia ( 11, 12 ). Ceramide is the backbone of com-
plex sphingolipids and is a very active metabolite ( 11 ). 
Increased ceramide synthesis in response to short periods of 
hypoxia induces DNA fragmentation and cell death ( 11, 13 ). 
Conversely, chronic exposure to hypoxia is characterized by 
the lack of ceramide accumulation ( 14 ) suggesting that a 
 Abstract  Fetal asphyctic  preconditioning, induced by a 
brief episode of experimental hypoxia-ischemia, offers neu-
roprotection to a subsequent more severe asphyctic insult at 
birth. Extensive cell stress and apoptosis are important con-
tributing factors of damage in the asphyctic neonatal brain. 
Because ceramide acts as a second messenger for multiple 
apoptotic stimuli, including hypoxia/ischemia, we sought to 
investigate the possible involvement of the ceramide path-
way in endogenous neuroprotection induced by fetal asphy-
ctic preconditioning. Global fetal asphyxia was induced in 
rats by clamping both uterine and ovarian vasculature for 
30 min. Fetal asphyxia resulted in acute changes in brain 
ceramide/sphingomyelin metabolic enzymes, ceramide 
synthase 1, 2, and 5, acid sphingomyelinase, sphingosine-1-
phosphate phosphatase, and the ceramide transporter. This 
observation correlated with an increase in neuronal apop-
tosis and in astrocyte number.  After birth, ceramide and 
sphingomyelin levels remained high in fetal asphyxia 
brains, suggesting that a long-term regulation of the cer-
amide pathway may be involved in the mechanism of 
tolerance to a subsequent, otherwise lethal, asphyctic 
event. —Vlassaks, E., C. Mencarelli, M. Nikiforou, E. Strackx, 
M. J. Ferraz, J. M. Aerts, M. H. De Baets, P. Martinez-Martinez, 
and A. W. D. Gavilanes.  Fetal asphyxia induces acute and 
persisting changes in the ceramide metabolism in rat brain. 
 J. Lipid Res. 2013. 54:  1825–1833. 
 Supplementary key words apoptosis • infl ammation • neonatal rat • 
neuroprotection • sphingomyelin 
 Perinatal asphyxia (PA) (hypoxia/ischemia) is one of the 
most common causes contributing to neonatal morbidity 
and mortality ( 1, 2 ). During periods of asphyxia, impaired 
gas exchange between mother and fetus occurs, leading to 
changes in blood gases and pH ( 3 ). As a consequence, asphy-
ctic newborns develop multi-organ dysfunction ( 4 ); with the 
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 Experimental design 
 Fetal asphyxia was induced as previously described by Strackx 
et al. ( 9 ). Briefl y, at E17 fetal asphyxia was induced by clamping 
both uterine and ovarian arteries with removable clamps for 
30 min ( Fig. 1A ). All pups were born by caesarean section (CS). 
Animals were sacrifi ced directly after CS performed at 6, 12, and 
72 h after the fetal asphyctic insult. Alternatively, CS was per-
formed at birth (E21) and animals were sacrifi ced at 2 h, 6 h, and 
7 days after CS (n = 6 for each group at every time point) ( Fig. 1B ). 
Control pups were born at the same time points by CS from un-
treated mothers. Pups belonging to the prenatal experimental 
groups were littermates from the same mother. The postnatal 
pups were born from at least two mothers. Total brain hemi-
spheres of fetal and neonatal pups were collected and snap-frozen. 
All samples were stored at   80°C prior to further analysis. 
 RNA isolation 
 Total brain hemispheres were collected at 6 and 12 h after the 
fetal asphyctic insult and 2 h, 6 h and 7 days after birth. Total RNA 
was extracted from frozen tissue by homogenization of the samples 
with TRIzol reagent (Invitrogen, Breda, The Netherlands) accord-
ing to the manufacturer’s guidelines. Quality and quantity of the 
RNA were determined using a Nanodrop ND-1000 spectro-
photometer (Thermo Scientifi c, Wilmington, MA). RNA integrity 
number values were determined using the Agilent 2100 Bioana-
lyzer (Agilent Technologies, Amstelveen, The Netherlands) and 
RNA samples with RNA integrity number > 8 were included. 
protective adaptive response to chronic hypoxia may ex-
ist. Because ceramide acts as a second messenger in apop-
tosis ( 15 ), its production is highly regulated and its levels 
inside the cell depend on the activity of several enzymes 
that participate in its synthesis and catabolism ( 11, 16, 
17 ). In this study, we aim to investigate acute changes oc-
curring in the sphingomyelin/ceramide pathway after a 
sublethal fetal asphyctic insult to identify molecules 
important in brain tolerance. Moreover, we study the 
crosstalk between ceramide metabolism and the brain 
apoptotic response. Better understanding of these mech-
anisms may allow the development of new neuroprotec-
tive therapies. 
 EXPERIMENTAL PROCEDURES 
 Animals 
 All experiments were approved by the Animal Ethics Board 
of Maastricht University on animal welfare according to Dutch 
governmental regulations. Timed-pregnant Sprague-Dawley 
rats (E14; Charles River, France) were kept under standard 
laboratory conditions (food and water given ad libitum, 21 ± 
2°C environment temperature, and a 12 h light/dark sched-
ule). Unsexed fetuses and male neonates were used within this 
study. 
 Fig. 1. Experimental design. Fetal asphyxia was induced at E17 by clamping the uterine vasculature for 30 min (A). At term birth, animals 
were delivered by caesarean section. Pups were euthanized at three different time points after fetal asphyxia prenatally and at three different 
time points postnatally (n = 6 per group per time point) (B). E, embryonic day; d, days. 
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Concord, MA) as a loading control. After PBS washes, mem-
branes were incubated with goat anti-rabbit-Alexa IRDye800CW 
(1:10,000 dilution; LI-COR Biosciences, Lincoln, NE) and donkey 
anti-mouse IRDye680DX conjugated (1:10,000 dilution; Rock-
land Immunochemicals, Gilbertsville, PA) for 1 h at room tem-
perature. Targeted proteins were analyzed using the LICOR 
Odyssey scanner (Li-Cor Bioscience, Westburg, Leusden, The 
Netherlands) and ImageJ software (National Institutes of Health, 
Bethesda, MD). 
 Measurement of sphingolipids 
 Sphingolipid levels were determined at 6 and 12 h after the fetal 
asphyctic insult and 2 h, 6 h, and 7 days after birth. Brain pieces were 
homogenized using a Zymo Research bead beater for 2 × 20 s at 
6 m/s in water yielding a 250 mg/ml tissue homogenate. Glycosphin-
golipid content was determined as previously described ( 20 ) with 
slight modifi cations. Briefl y, 50   l of brain homogenate was ex-
tracted with 600   l of CHCl 3 /methanol 1/2 (v/v). The extract was 
centrifuged for 10 min at 13,200 rpm and the pellet discarded. Five 
hundred and ten microliters of CHCl 3 /MQ-H 2 O 1/1.3 (v/v) was 
added, mixed, and centrifuged for 3 min at 13,200 rpm to separate 
the phases. The lower phase was collected and the upper phase re-
extracted with 400   l of CHCl 3 . The combined lower phases were 
dried under N 2 fl ow, taken up in 500   l of freshly prepared 0.1 M 
NaOH in methanol, and deacylated in a microwave (SAM-155, CEM 
Corp.) for 60 min. Fifty microliters of this solution was derivatized 
with 25   l ortho-phthalaldehyde (OPA) reagent. The OPA-deriva-
tized lipids were separated by HPLC and quantifi ed as previously 
described, using C17 sphinganine as an internal standard 
(Avanti Polar Lipids, Alabaster, AL) ( 20 ). Sphingomyelin content was 
determined by incubating the samples with 125 mU of sphingomyeli-
nase from  Bacillus cereus (Sigma-Aldrich, St. Louis, MO) for 1 h at 
37°C. The samples were then extracted as previously described (20), 
glycosphingolipids and sphingomyelin levels where calculated by sub-
tracting the ceramide levels from treated and nontreated samples . 
 Flow cytometric analysis 
 At 72 h after fetal asphyxia, brains were collected for fl uores-
cence-activated cell sorting (FACS) analysis. Total brains were 
placed in ice-cold plating medium consisting of DMEM supple-
mented with 10% fetal bovine serum (FBS), penicilline/strepta-
vidine, and glutamate. The tissue was mechanically disrupted 
using a glass homogenizer. The cell suspension was centrifuged 
and the pellet was resuspended in 5 ml of plating medium. The 
crude cell suspension was then passed through a 100   m nylon 
 Reverse transcription 
 cDNA was synthesized by using the RevertAid First Strand 
cDNA synthesis kit (Fermentas, St. Leon Rot, Germany) according 
to the manufacturer’s protocol. The samples were diluted 1 to 20 
with DEPC -treated sterilized water and stored at   80°C prior to 
quantitative PCR analysis. 
 Real-time PCR 
 Primers were designed using Primer3plus (http://www.
bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi, Boston, 
MA) for the ceramide transporter protein (CERT), Goodpasture 
antigen-binding protein (GPBP), LAG1 homolog ceramide synthase 
(Lass)1 to Lass6, neutral sphingomyelinase 1 and 2 (nSMase1-2), 
acid sphingomyelinase (aSMase), sphingomyelin synthase 1 and 2 
(SMS1-2), sphingosine kinase 1 (SphK1), sphingosine-1-phosphate 
phosphatase (Sph1PP), and oxysterol-binding protein 1 (OSBP1) 
( Table 1 ). All samples were analyzed in duplicate using the LightCy-
cler 480 SYBR Green I Master kit (Roche, Almere, The Nether-
lands). Samples negative for RevertAid Reverse Transcriptase were 
used as control to ensure specifi c amplifi cation. The real-time PCR 
was performed on a LightCycler 480 system (Roche) with 45 cycles: 
20 s at 95°C, 15 s at 60°C, 15 s at 72°C. To standardize for the amount 
of cDNA, the geometric mean of three reference genes,   -actin, hy-
poxanthine-guanine phosphoribosyltransferase (HPRT), and glyc-
eraldehyde-3-phosphate dehydrogenase (GAPDH) ( Table 1 ), was 
used. Quantifi cation cycle values were analyzed with the Lightcycler 
480 software (Conversion LC 480 and LingRegPCR version 9.19  ) 
and calculated based on the cycle threshold (Ct) values. 
 Western blotting 
 Frozen brain hemispheres were collected at 6 and 12 h after 
the fetal asphyctic insult and 2 h, 6 h, and 7 days after birth and 
homogenized in CelLytic MT Mammalian Tissue Lysis/Extrac-
tion reagent (Sigma-Aldrich, St. Louis, MO). The samples were 
then centrifuged at 15,000  g for 10 min. The protein-containing 
supernatants were collected and the concentration of total pro-
tein was measured by Bradford , using BSA as a standard ( 18 ). 
 Equal amounts of total protein (30   g) from each sample were 
separated using 10% SDS-PAGE gels and transferred onto a ni-
trocellulose membrane (Millipore, Amsterdam, The Netherlands). 
Blocking was performed with 5% BSA. Next, the membranes 
were incubated overnight at 4°C using rabbit polyclonal anti-
GPBP/CERT (1:5,000 dilution, epitope 1-50 of human GPBP; Bethyl 
Laboratories, Montgomery, TX) ( 19 ) and with monoclonal mouse 
anti-rabbit GAPDH (1:2,000,000 dilution; Fitzgerald Industries, 
 TABLE 1. Primer sequences for the selected genes of interest for quantitative PCR analysis 
Gene Accession number Forward sequence (5 ′ -3 ′ ) Reverse sequence (5 ′ -3 ′ )
  -actin NM_031144.3 TTGCTGACAGGATGCAGAAG TGATCCACATCTGCTGGAAG
GAPDH NM_017008.4 CTCCCATTCTTCCACCTTTG ATGTAGGCCATGAGGTCCAC
HPRT NM_012583.2 TTGCTGGTGAAAAGGACCTC TCCACTTTCGCTGATGACAC
CERT NM_005713.2 ATAGAGGAACAGTCACAGAGTG CTGTACCATCTCTTCAACCTTTTG
GPBP NM_005713.2 ATGTCCACAGATTCAGCTCCC CTTCTTCTACAACCAGCTGCC
Lass1 NM_001044230.2 CTTCTTCAACACTCTGCTGCTG TCTTCCAGTTCACGCATCTCG
Lass2 NM_001033700 GCCTTTGACTCCCTGACTTCA GGGGTAGGGTGAGGGCATGTA
Lass3 NM_001127561 CTGGCTTCCTCCGACAATAAA GGTGTGGCAACAAACTTTTCAAA
Lass4 NM_001107117 GTGGCTGTGGCAGGAGACATA GCAAGGCCACGAATCTCTCAA
Lass5 NM_001108993 GGATGCTGTTCGAGCGATTTA CATCCCAGTCCAGTTGCTTTGA
Lass6 XM_345363 CAGCGACACAGGAGTGGACAA CGCACCATGAAGATGCAGAA
nSMase1 NM_031360.2 TCAGGAAGACCCTTGCTCTG GACAGCCCCAAAATCATCAC
nSMase2 NM_053605 TGAAAACATTATTGAGCCTTGC CTTTGCCACAGCCAATGTC
aSMase NM_001006997.1 TGACTCTAAGGGATGGAAGCC AAAAGAGGGTGGAGAAGGGG
SMS1 NM_181386.2 GGTATCACACGATGGCCAAT GATCGAGGTACAATCCCTTGG
SMS2 DQ071571 ACATCCAGATTTCCATGCCC AAGAGAGCGTACACAAAGGC
SphK1 NM_001270811.1 AAACCCCTATGTAGCCTCCC TAGTGACCTGCTCGTGCC
Sph1PP NM_001191811.1 CACGTTACCCTTAGCTATCCC CAACATCCCTATGACGACCC
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argon ion laser (488 nm). Analysis was done using the Cell Quest 
Pro software (BD Biosciences). Forward and sideward light angle 
scatters were collected from all samples. Samples were gated (R1) to 
exclude cell debris and cellular aggregates for further analysis. For 
each marker, the mean fl uorescence intensity and the percentage of 
positive cells stained above background were measured for a total of 
10,000 cells per sample within the gate (R1). The cut off was defi ned 
using control tissue negative for the different markers processed 
and stained alongside the experimental samples. The mean fl uores-
cence intensity was corrected for autofl uorescence using the values 
from cells only incubated with secondary antibody. 
 Statistical analysis 
 All results were expressed as mean + SEM . Statistical analyses 
were conducted using GraphPad Prism software. Normality was 
tested using the Kolmogorov-Smirnov test. All results were nor-
mally distributed. Comparisons between control and fetal asphy-
ctic animals were analyzed using unpaired  t -test, one-way ANOVA, 
or two-way ANOVA with Bonferroni post hoc test.  P < 0.05 was 
considered statistically signifi cant. 
 RESULTS 
 A global fetal asphyctic preconditioning stimulus 
induces neuroprotection by lowering the amount of 
ap optotic cell death in PA animals ( 10 ) preserving both 
locomotor activity and cognitive function ( 9 ). Because ce-
ramide is an important regulator of cell growth and apop-
tosis ( 22 ), we studied the acute effect of fetal asphyxia in 
the ceramide signaling pathway ( Fig. 2 ) at several prenatal 
and postnatal time points ( Fig. 1B ). 
cell strainer to remove large cell clumps. Next, cells numbers 
were counted using a Bürker’s chamber and divided into differ-
ent Eppendorf tubes (10 6 cells/0.5 ml per tube). The viability of 
the cells was monitored using trypan blue ( 21 ). 
 Apoptotic and necrotic cells were detected with AnnexinV con-
jugated to FITC and propidium iodide. The staining was executed 
according to the manufacturer’s instructions (AnnexinV-FITC 
Apoptosis Detection Kit; BD Biosciences Pharmingen, Breda, 
The Netherlands). 
 To identify different cell types, extracellular staining for OX42 
(microglia) and intracellular staining for GFAP (astroglia), CNPase 
(oligodendrocytes), and NF-200 (neurons) was performed. Shortly, 
the cells were washed with staining buffer (PBS + 2% FBS). After 
washing, cells were incubated for 30 min at room temperature with 
the primary antibody: mouse anti-rat CD11b/c (clone OX42, BD 
Pharmingen, 1:100 dilution). The cells were washed twice followed 
by incubation with the secondary antibody (donkey anti-mouse 
alexa 488, 1:100 dilution). For intracellular staining, cells were 
fi xed with 4% paraformaldehyde in staining buffer for 20 min at 
room temperature. Permeabilization was done after two more 
washing steps with permeabilization buffer (0.05% saponin + 2% 
FBS + PBS) for 10 min at room temperature. The cell suspension 
was then incubated with the primary antibody for 30 or 45 min at 
room temperature: mouse anti-ovine CNPase (Clone 11-5B, 1:200 
dilution; Sigma-Aldrich), rabbit anti-ovine GFAP (1:200 dilution; 
DAKO, Heverlee Belgium), and mouse anti-NF-200 (1:100 dilution; 
Abcam, Cambridge, UK). After two washing steps, the cell suspen-
sion was incubated with the secondary antibody (donkey anti-mouse 
or donkey anti-rabbit alexa 488, 1:100 dilution) for 30 min at room 
temperature. Finally, all samples were washed and kept at 4°C in 
the dark until analysis. 
 All samples were measured on a FACScalibur fl ow cytometry sys-
tem (BD Biosciences, Breda, The Netherlands) equipped with an 
 Fig. 2. Ceramide metabolism pathway. Ceramide can be generated by the activity of three general pathways.  i ) The de novo pathway that 
occurs at the cytosolic surface of the ER from condensation of L-serine with palmitoyl CoA. Once formed, de novo-generated ceramide is 
transported by CERT/GPBP to the Golgi apparatus and  ii ) converted to sphingomyelin by sphingomyelin synthase (SMS) (sphingomyeli-
nase pathway) or to glucosylceramide (GalCer + GlcCer).  iii ) The salvage pathway, that takes place at the membrane of different organelles 
in which ceramide is formed by degradation of sphingomyelin by different sphingomyelinases (SMases). Ceramide generated in lysosomes 
can be used as a substrate for acid ceramidase for the generation of sphingosine and, from this, the generation of sphingosine-1-phosphate 
in other compartments. SphK, sphingosine kinase; Sph1PP, sphingosine-1-phosphate phosphatase. 
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( 25 ) were increased after fetal asphyxia compared with un-
treated controls (aSMase,  P = 0.002; Sph1PP,  P = 0.039) 
( Fig. 3 ). Once generated in the endoplasmatic reticulum 
(ER), ceramide must be transported by CERT/GPBP to 
the Golgi apparatus in order to be converted to more com-
plex sphingolipids ( 17 ). Fetal asphyxia signifi cantly in-
creased CERT/GPBP mRNA synthesis ( P = 0.045), however, 
we found CERT/GPBP protein levels reduced after fetal 
asphyxia ( P = 0.033) ( Fig. 3 , bottom right). This suggests 
that the increased mRNA synthesis of CERT/GPBP is a 
compensatory response caused by a reduction in CERT/
GPBP protein levels, probably to increase ceramide trans-
port for the production of sphingomyelin. 
 Using HPLC, we investigated whether the changes in cer-
amide enzymes lead to changes in ceramide and ceramide 
metabolite levels. Ceramide and sphingomyelin levels were 
unaffected shortly after fetal asphyxia (data not shown), sug-
gesting that this phase is mainly characterized by alterations 
at transcriptional level. 
 Changes in mRNA levels of enzymes involved in 
ceramide metabolism at 6 and 12 h after fetal asphyxia 
 To investigate whether ceramide metabolism genes 
change at 6 and 12 h after fetal asphyctic preconditioning, 
we examined by RT-PCR the expression of several enzymes 
involved in ceramide metabolism: Lass1 to Lass6, SMS1-2, 
aSMase, nSMase1-2, SphK1, and Sph1PP. We observed sig-
nifi cant mRNA changes in ceramide synthases [the en-
zymes which convert sphinganine to ceramide ( 23 )], Lass1 
( P = 0.021), Lass2 ( P = 0.006), and Lass5 ( P = 0.016) after 
fetal asphyxia ( Fig. 3 ). No signifi cant changes were seen in 
mRNA levels of SMS1 and SMS2, which catalyze the forma-
tion of sphingomyelin from ceramide ( 11 ), nSMase1 and 
-2, which break down sphingomyelin to generate ceramide 
( 24 ), and SphK1, which catalyzes the phosphorylation of 
sphingosine to form sphingosine-1-phosphate ( Fig. 3 ). On 
the other hand, aSMase which is localized in lysosomes 
and regulates cellular membrane turnover ( 17 ), and Sph1PP 
involved in regulating levels of sphingosine-1-phosphate 
 Fig. 3. Changes in mRNA and protein levels of enzymes involved in ceramide metabolism at 6 and 12 h after fetal asphyxia. A: Prenatal 
relative mRNA levels of Lass1 to Lass6, nSMase1-2, aSMase, SMS1-2, SPK1, Sph1PP, and CERT/GPBP in control and fetal asphyctic animals. 
mRNA levels are relative to the geomean of measured housekeeping genes and normalized to control levels. B: Relative protein levels of 
CERT/GPBP normalized to GAPDH as loading control 6 and 12 h after fetal asphyxia with corresponding control levels. Comparisons 
between control and fetal asphyctic animals were analyzed using one-way ANOVA;  P < 0.05 is indicated for each particular gene/protein. 
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7 days after birth ( Fig. 1B ) in fetal asphyxia-subjected ani-
mals and controls. At all postnatal time points, ceramide 
levels were increased after fetal asphyxia ( P < 0.0005) 
( Fig. 6A ). Sphingomyelin levels were also increased af-
ter fetal asphyxia ( P < 0.02) ( Fig. 6B ). Because the re-
covered ceramide and sphingomyelin amounts in our 
rat brain samples were relatively low compared with sim-
ilar sphingolipids recovered from adult mouse brain 
( 28 ), we tested whether the amount of SMase used in our 
assay to determine sphingomyelin concentration in the 
brain samples was suffi cient . We incubated the brain 
samples with fi ve times more SMase and this did not 
result in detection of more ceramide (supplementary 
Table I). Additionally, we investigated a potential nega-
tive matrix effect by brain lipids on ceramide detection. 
Therefore we spiked brain samples with a known amount 
of ceramide and looked for the recovery of this spike. 
These results showed that ceramide measurements were 
not altered in our samples (supplementary Table I). 
 To correlate the observed changes in ceramide/sphingo-
myelin levels to expression of genes of the ceramide path-
way, we tested by real-time PCR the same set of genes studied 
prenatally. We found a signifi cant increase in mRNA levels 
of aSMase after fetal asphyxia ( P < 0.0004) ( Fig. 6C ). Ad-
ditionally, we could detect a signifi cant upregulation of 
GPBP/CERT protein levels at 7 days after birth ( P < 0.05) in 
fetal asphyxia subjected animals ( Fig. 6D ). This increase 
in sphingolipids in fetal asphyctic animals after birth sug-
gests the persistent activation of the catabolic as well as the 
de novo ceramide metabolic pathways. 
 OSBP1 levels are increased 6 h after fetal asphyxia 
 We investigated if fetal asphyxia could also acutely af-
fect other genes involved in lipid metabolism. We studied 
OSBP1, a member of a family of sterol-binding proteins, 
with structural homology to GPBP/CERT ( 17 ). We found 
a signifi cant increase in OSBP1 mRNA levels 6 h after 
fetal asphyxia compared with controls ( P < 0.001) ( Fig. 4 ). 
However, there was no signifi cant increase in OSBP1 
mRNA levels at 12 h after fetal asphyxia compared with 
controls ( P > 0.05). The on-off effect of fetal asphyxia 
on OSBP1 mRNA levels is in marked contrast to the 
long-lasting effects of fetal asphyxia on some ceramide 
metabolism genes which remained affected 12 h after fe-
tal asphyxia ( Fig. 3 ). 
 Increased neuronal apoptosis and increased astroglia cell 
numbers in fetal asphyctic brain 
 Growing evidence indicates a signaling role for cer-
amide in asphyxia-induced apoptosis ( 26, 27 ). To deter-
mine the effects of ceramide changes on apoptotic levels, 
we quantifi ed the amount of live apoptotic and necrotic 
cells in total brain of control versus fetal asphyctic animals 
by FACS analysis at 72 h post-fetal asphyxia.  Figure 5A 
shows that although approximately 35% of the cells un-
dergo apoptosis (due to normal development and the 
used methodology), the amount of live cells decreased af-
ter fetal asphyxia (unpaired  t -test,  P < 0.001) due to in-
creased apoptosis (unpaired  t -test,  P = 0.002) but not 
necrosis, and that neurons contribute most to this increase 
in apoptosis (unpaired  t -test,  P = 0.04) ( Fig. 5B ). More-
over, the asphyctic brain has larger numbers of astrocytes 
than the control brain (unpaired  t -test,  P = 0.005) ( Fig. 5B ). 
In conclusion, fetal asphyxia induces increased numbers 
of apoptotic cells, less neurons, and more astrocytes. 
 Increased ceramide levels are sustained until 
7 days after birth 
 To investigate whether the changes in ceramide me-
tabolism after sublethal fetal asphyxia would persist 
after birth, we assessed ceramide synthesis 2 h, 6 h, and 
 Fig. 4. OSBP1 levels are increased 6 h after fetal asphyxia. Prena-
tal relative mRNA levels of OSBP1 in control and fetal asphyctic 
animals. mRNA levels are relative to the geomean of measured 
housekeeping genes and normalized to control levels. Compari-
sons between control and fetal asphyctic animals were analyzed us-
ing one-way ANOVA and with Bonferroni post hoc test,  P < 0.033. 
 Fig. 5. Increased neuronal apoptosis and increased astroglia cell 
numbers in fetal asphyxia brain. Amount of live, apoptotic, and 
necrotic cells (A) and amount of specifi c cell types (B) 72 h after 
fetal asphyxia compared with respective control levels. Data shown 
as mean + SEM . Comparisons between control and fetal asphyctic 
animals were analyzed using unpaired  t -test,  P < 0.05 is indicated. 
White bars represent control and black bars, fetal asphyxia brain. 
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increased after severe perinatal asphyxia compared with 
preconditioned animals (fetal asphyxia-PA) ( 9 ). 
 We found acute prenatal and postnatal changes in ce-
ramide metabolism genes. In particular Lass1 and Lass2 
genes were upregulated and Lass5 downregulated pre-
natally after fetal asphyxia compared with controls. Six 
isoforms of Lass enzyme have been identifi ed, each re-
sponsible for the synthesis of ceramides of distinct fatty 
acid length ( 33 ). Increased ceramide synthase activity 
has been shown following a brief exposure to hypoxia 
and oxygen/glucose deprivation ( 34, 35 ) to promote 
the synthesis of ceramide, sphingomyelin, and glycosphin-
golipids ( 23 ). It is not clear which Lass isoform is spe-
cifi cally responsible for the asphyxia-induced ceramide 
synthesis because data suggest that changes in ceramide 
synthase expression can be counter-regulated by changes 
in the other Lass isoforms ( 36 ). However results from 
our rat asphyxia model show that Lass1 and Lass2 are 
acutely sensitive to oxygen limitation and suggest that 
they may be partially responsible for the postnatal in-
crease in ceramide levels. Other ceramide metabolism 
genes that are sensitive to asphyxia are aSMase, Sph1PP 
(salvage pathway), and CERT/GPBP (de novo pathway). 
These genes are all acutely upregulated after fetal as-
phyxia. In the salvage pathway aSMase forms ceramide 
via lysosomal catabolism of sphingomyelin and Sph1PP 
catalyzes the degradation of S1P and recycling of sphin-
gosine into long-chain ceramides ( 37 ). Both aSMase and 
Sph1PP sensitivity to acute cellular oxygen changes has 
already been reported ( 15, 23, 38, 39 ). Additionally, we 
found that mRNA levels of the ceramide transporter 
CERT/GPBP were elevated before birth after fetal as-
phyxia. In contrast, protein levels of CERT/GPBP were 
found to be reduced. As CERT/GPBP is responsible for 
the transport of ceramide to the Golgi, it is possible that 
 DISCUSSION 
 In the present study, we found evidence for acute and per-
sisting changes in the ceramide metabolism in the brain due 
to fetal asphyxia. Before birth, Fetal asphyxia induced a rapid 
upregulation in expression levels of Lass1, Lass2, aSMase, 
CERT/GPBP, and Sph1PP and downregulation of Lass5, 
higher apoptotic cell rate, and increased glia cell numbers. 
After birth, ceramide and sphingomyelin were found ele-
vated in brains of fetal asphyxia subjected animals. To-
gether, these data demonstrate that fetal asphyxia induces an 
increase in ceramide levels in the brain and suggest that cer-
amide may have a role for the observed neuroprotection 
against a later more severe insult. 
 Many studies investigated the induction of tolerance to 
hypoxic-ischemic insults. Nevertheless, the mechanism by 
which a period of sublethal fetal asphyxia can provide neuro-
protection against a subsequent more severe insult is not 
completely understood. Changes in ceramide levels have 
been reported in various models of hypoxia. Previously, we 
reported that an asphyctic episode before birth can induce 
chronic changes in expression levels of ceramide metabo-
lism genes in the brain ( 29 ). Our work suggested that the 
combination of two subsequent asphyctic insults provides 
long-lasting brain neuroprotection probably by maintaining 
normal apoptosis and promoting cell proliferation. Here, we 
investigated if ceramide metabolism changes can also be ob-
served acutely after fetal asphyxia. We studied early time 
points (6, 12, and 72 h before birth and 2 and 6 h after 
birth) and a late time point (7 days after birth). We ana-
lyzed the ceramide pathway at early time points because it 
has been described that hypoxia can induce early infl am-
matory changes in the brain ( 30, 31 ) and ceramides have 
been associated to infl ammation ( 32 ). Additionally, we in-
cluded 7 days after birth because at this time point we have 
previously demonstrated in our model that apoptosis is 
 Fig. 6. Increased ceramide levels 
are sustained until 7 days after birth. 
Ceramide (A) and sphingomyelin 
(B) concentrations expressed in 
nmol/mg protein in control (white 
bars) and fetal asphyxia (black bars) 
animals. mRNA levels of aSMase 
(C) are presented relative to the geo-
mean of measured housekeeping 
genes. Relative protein levels of 
CERT/GPBP normalized to GAPDH 
as loading control in control (white 
bars) and fetal asphyxia (black bars) 
animals (D). Data shown as mean + 
SEM. Comparisons between control 
and fetal asphyctic animals were 
analyzed using two-way ANOVA; 
 P < 0.05 is indicated for each partic-
ular gene/protein. White bars rep-
resent control and black bars fetal 
asphyxia brain. 
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injury ( 15, 27, 38 ). However, this effect of ceramide was 
observed in a chronic model of ischemia and the induc-
tion of ischemia was in older animals. On the other 
hand, in hippocampal and cortical neurons it has been 
suggested that ceramide induces protection against 
injury, apoptosis, and free radical forms ( 26 ) and can 
mediate hypoxia tolerance induced by hypoxic precon-
ditioning ( 42 ).  ii ) Neuronal cell death occurs during 
normal brain development and may serve a variety of 
biological functions including the elimination of cells 
carrying abnormalities ( 43 ), and its dysregulation re-
sults in developmental brain pathology ( 26, 44 ).  iii ) 
Apoptotic cells can protect the tissue-reducing levels of 
circulating cytokines ( 45 ). In our model we observed 
postnatally that several cytokines are upregulated at the 
transcriptional level in fetal asphyxia-treated animals 
compared with controls ( 40 ). Increased apoptosis might 
be a mechanism to reduce brain injury after fetal as-
phyxia including infl ammatory damage. 
 Finally we also observed larger numbers of astrocytes in 
fetal asphyctic brains. Other studies have shown increased 
cell numbers after hypoxic-ischemic brain injury. One of the 
explanations for this may be that the neonatal animal re-
sponds to brain injury with cell proliferation to stimulate re-
covery ( 46, 47 ). 
 In summary, fetal asphyxia induced a rapid upregulation 
of enzymes involved in ceramide metabolism leading to the 
upregulation of ceramide and increased apoptosis. Fol-
low-up studies should focus on targeting enzymes which 
are found differentially regulated after fetal asphyxia and 
the combination of fetal asphyxia with a subsequent severe 
asphyctic insult to further study their potentially protective 
effect against asphyxia.  
 The authors thank Fabian Loidl (MD, PhD) for his help in 
Figure 1A. 
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